| |
| |
|
| Insider
Information: |
Broom Colin Md |
| Relationship: |
Director |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
36,523 |
|
|
Indirect Shares
|
72,849 |
|
|
| Direct
Value |
$14,383 |
|
|
|
Indirect Value
|
$28,688 |
|
|
| Total
Shares |
109,372 |
|
|
| Total
Value |
$43,071 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -39.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viropharma Inc |
VPHM |
VP & Chief Scientific ... |
2014-01-24 |
0 |
2008-09-12 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
36,523 |
2018-06-22 |
72,849 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2022-08-02 |
4 |
S |
$0.19 |
$1,015 |
D/D |
(5,339) |
36,523 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2021-08-02 |
4 |
S |
$1.20 |
$637 |
D/D |
(531) |
41,862 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
42,393 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2020-08-20 |
4 |
S |
$0.65 |
$7,165 |
D/D |
(11,064) |
248,936 |
0 |
% |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,750 |
260,000 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
226,250 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2019-08-30 |
4 |
B |
$2.03 |
$20,668 |
D/D |
10,177 |
208,750 |
2.39 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2019-08-21 |
4/A |
S |
$2.07 |
$21,066 |
D/D |
(10,177) |
125,724 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2019-08-21 |
4 |
D |
$2.07 |
$21,066 |
D/D |
(10,177) |
125,724 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,750 |
135,901 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
CEO & Director |
• • – |
2018-06-22 |
4 |
B |
$3.72 |
$18,600 |
D/D |
5,000 |
102,151 |
2.81 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
CEO & Director |
• • – |
2018-05-23 |
4 |
B |
$4.60 |
$46,000 |
D/D |
10,000 |
97,151 |
2.81 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive Officer |
• • – |
2017-09-22 |
4 |
B |
$8.35 |
$21,610 |
D/D |
2,588 |
87,151 |
2.81 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive OfficerOfficer |
• – – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
159 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Executive OfficerOfficer |
• – – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,582 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2015-02-21 |
4 |
D |
$46.00 |
$1,118,398 |
D/D |
(24,313) |
0 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
24,313 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,878) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,878 |
48,878 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$7,702,900 |
D/D |
(154,058) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2014-01-08 |
4 |
D |
$49.80 |
$1,002,972 |
D/D |
(20,140) |
154,058 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2014-01-08 |
4 |
OE |
$1.84 |
$740,574 |
D/D |
142,142 |
156,192 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2013-02-07 |
4 |
AS |
$8.74 |
$53,314 |
D/D |
(6,100) |
9,125 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,225 |
15,225 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
• • – |
2012-12-27 |
4 |
OE |
$1.84 |
$18,400 |
D/D |
10,000 |
30,167 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
